Crossmark

Societal cost-effectiveness analysis of the 21-gene assay in estrogen-receptor–positive, lymph-node–negative early-stage breast cancer in Japan

Crossref DOI link: https://doi.org/10.1186/1472-6963-14-372

Published Online: 2014-09-05

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Yamauchi, Hideko

Nakagawa, Chizuko

Yamashige, Shinji

Takei, Hiroyuki

Yagata, Hiroshi

Yoshida, Atsushi

Hayashi, Naoki

Hornberger, John

Yu, Tiffany

Chao, Calvin

Yoshizawa, Carl

Nakamura, Seigo
License Information

License valid from 2014-09-05
More Information

Article History

Received: 12 December 2013

Accepted: 29 August 2014

First Online: 5 September 2014